Four-year analysis of cardiovascular disease risk factors, depression symptoms, and antidepressant medicineuse in the lookahead (action for health in diabetes) clinical trial of weight loss in diabetes

Diabetes Care

Volumn 36, Issue 5, 2013, Pages 1088-1094

  Rubin, Richard R ^a   Peyrot, Mark ^b   Gaussoin, Sarah A ^c   Espeland, Mark A ^c   Williamson, Don ^d   Faulconbridge, Lucy F ^e   Wadden, Thomas A ^e   Ewing, Linda ^f   Safford, Monika ^g   Evans Hudnall, Gina ^h,i   Wing, Rena R ^j   Knowler, William C ^k  

^a JOHNS HOPKINS UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b LOYOLA UNIVERSITY MARYLAND   (United States)

^c WAKE FOREST SCHOOL OF MEDICINE   (United States)

^d PENNINGTON BIOMEDICAL RESEARCH CENTER   (United States)

^e UNIVERSITY OF PENNSYLVANIA   (United States)

^f UNIVERSITY OF PITTSBURGH SCHOOL OF MEDICINE   (United States)

^g UNIVERSITY OF ALABAMA SCHOOL OF MEDICINE   (United States)

^h VETERANS AFFAIRS MEDICAL CENTER   (United States)

ⁱ BAYLOR COLLEGE OF MEDICINE   (United States)

^j BROWN UNIVERSITY   (United States)

^k NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES   (United States)

more..

Author keywords

[No Author keywords available]

Indexed keywords

ANTIDEPRESSANT AGENT; CHOLESTEROL; HEMOGLOBIN A1C; HIGH DENSITY LIPOPROTEIN; INSULIN; TRIACYLGLYCEROL;

ADULT; AGED; ARTICLE; BECK DEPRESSION INVENTORY; CARDIOVASCULAR RISK; CONTROLLED STUDY; DEPRESSION; DIABETES EDUCATION; DIABETIC DIET; DISEASE ASSOCIATION; DISEASE DURATION; FEMALE; HUMAN; LIFESTYLE MODIFICATION; MAJOR CLINICAL STUDY; MALE; MEDICAL HISTORY; NON INSULIN DEPENDENT DIABETES MELLITUS; OBESITY; PREDICTION; PSYCHIATRIC TREATMENT; PSYCHOLOGIC ASSESSMENT; RANDOMIZED CONTROLLED TRIAL (TOPIC); RISK ASSESSMENT; RISK FACTOR; SMOKING HABIT; SYSTOLIC HYPERTENSION; WEIGHT REDUCTION;

AGED; ANTIDEPRESSIVE AGENTS; CARDIOVASCULAR DISEASES; DEPRESSION; DIABETES MELLITUS, TYPE 2; FEMALE; HUMANS; MALE; MIDDLE AGED; RISK FACTORS; WEIGHT LOSS;

EID: 84876786410     PISSN: 01495992     EISSN: 19355548     Source Type: Journal    
DOI: 10.2337/dc12-1871     Document Type: Article

References (34)

1. Egede LE, Nietert PJ, Zheng D. Depression and all-cause and coronary heart disease mortality among adults with and without diabetes. Diabetes Care 2005;28:1339-1345 (Pubitemid 40756694)
2. Egede LE, Zheng D. Independent factors associated with major depressive disorder in a national sample of individuals with diabetes. Diabetes Care 2003;26:104-111 (Pubitemid 36929001)
3. Lett HS, Blumenthal JA, Babyak MA, et al. Depression as a risk factor for coronary artery disease: evidence, mechanisms, and treatment. Psychosom Med 2004;66:305-315 (Pubitemid 38668397)
4. van Melle JP, de Jonge P, Spijkerman TA, et al. Prognostic association of depression following myocardial infarction with mortality and cardiovascular events: A meta-analysis. Psychosom Med 2004;66:814-822 (Pubitemid 39552863)
5. Hamer M, David Batty G, Seldenrijk A, Kivimaki M. Antidepressant medication use and future risk of cardiovascular disease: the Scottish Health Survey. Eur Heart J 2011;32:437-442
6. Cohen HW, Gibson G, Alderman MH. Excess risk of myocardial infarction in patients treated with antidepressant medications: Association with use of tricyclic agents. Am J Med 2000;108:2-8 (Pubitemid 30058271)
7. Taylor CB, Youngblood ME, Catellier D, et al.; ENRICHD Investigators. Effects of antidepressant medication on morbidity and mortality in depressed patients after myocardial infarction. Arch Gen Psychiatry 2005;62:792-798 (Pubitemid 41002762)
8. Thombs BD, de Jonge P, Coyne JC, et al. Depression screening and patient outcomes in cardiovascular care: A systematic review. JAMA 2008;300:2161-2171
9. O'Connor CM, Jiang W, Kuchibhatla M, et al.; SADHART-CHF Investigators. Safety and efficacy of sertraline for depression in patients with heart failure: results of the SADHART-CHF (Sertraline Against Depression and Heart Disease in Chronic Heart Failure) trial. J Am Coll Cardiol 2010;56:692-699
10. Rubin RR, Knowler WC, Ma Y, et al.; Diabetes Prevention Program Research Group. Depression symptoms and antidepressant medicine use in Diabetes Prevention Program participants. Diabetes Care 2005;28: 830-837 (Pubitemid 40434481)
11. Rubin RR, Ma Y, Marrero DG, et al.; Diabetes Prevention Program Research Group. Elevated depression symptoms, antide-pressant medicine use, and risk of developing diabetes during the diabetes prevention program. Diabetes Care 2008; 31:420-426
12. Rubin RR, Gaussoin SA, Peyrot M, et al.; Look AHEAD Research Group. Cardiovascular disease risk factors, depression symptoms and antidepressant medicine usein the Look AHEAD (Actionfor Health in Diabetes) clinical trial of weight loss in diabetes. Diabetologia 2010;53:1581-1589
13. Ryan DH, Espeland MA, Foster GD, et al.; Look AHEAD Research Group. Look AHEAD (Action for Health in Diabetes): design and methods for a clinical trial of weight loss for the prevention of cardiovascular disease in type 2 diabetes. Control Clin Trials 2003;24: 610-628
14. The Look AHEAD Research Group. Baseline characteristics of the randomized cohort for the Look AHEAD (Action for Health in Diabetes) study. Diab Vasc Dis Res 2006;3:202-215
15. Beck AT, Steers RA. Manual of the Beck Depression Inventory. San Antonio, TX, Psychological Corporation, 1993
16. American Diabetes Association. Standards of medical care in diabetes. Diabetes Care 2005;28(Suppl. 1):S4-S36
17. Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults. Executive Summary of The Third Report of The National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, And Treatment of High Blood Cholesterol In Adults (Adult Treatment Panel III). JAMA 2001; 285: 2486-2497
18. Giorda CB, Avogaro A, Maggini M, et al.; Diabetes and Informatics Study Group. Recurrence of cardiovascular events in patients with type 2 diabetes: epidemiology and risk factors. Diabetes Care 2008;31:2154-2159
19. Cederholm J, Eeg-Olofsson K, Eliasson B, Zethelius B, Nilsson PM, Gudbjörnsdottir S; Swedish National Diabetes Register. Risk prediction of cardiovascular disease in type 2 diabetes: A risk equation from the Swedish National Diabetes Register. Diabetes Care 2008;31:2038-2043
20. Diggle PJ, Liang KY, Zeger SL. Analysis of Longitudinal Data. New York, NY, Oxford University Press, 1994
21. Eeg-Olofsson K, Cederholm J, Nilsson PM, et al. New aspects of HbA1c as a risk factor for cardiovascular diseases in type 2 diabetes: An observational study from the Swedish National Diabetes Register (NDR). J Intern Med 2010;268:471-482
22. Mason PJ, Manson JE, Sesso HD, et al. Blood pressure and risk of secondary cardiovascular events in women: the Women's Antioxidant Cardiovascular Study (WACS). Circulation 2004;109:1623-1629 (Pubitemid 38451718)
23. Nordestgaard BG, Chapman MJ, Ray K, et al.; European Atherosclerosis Society Consensus Panel. Lipoprotein(a) as a cardiovascular risk factor: current status. Eur Heart J 2010;31:2844-2853
24. Guallar E, Banegas JR, Blasco-Colmenares E, et al. Excess risk attributable to traditional cardiovascular risk factors in clinical practice settings across Europe-The EURIKA Study. BMC Public Health 2011;11:704
25. McGee DL; Diverse Populations Collaboration. Body mass index and mortality: A meta-analysis based on person-level data from twenty-six observational studies. Ann Epidemiol 2005;15:87-97 (Pubitemid 40126638)
26. Lederbogen F, Gilles M, Maras A, et al. Increased platelet aggregability in major depression? Psychiatry Res 2001;102:255-261 (Pubitemid 32607564)
27. Coyne JC. Self-reported distress: Analog or Ersatz depression? Psychol Bull 1994; 116:29-45 (Pubitemid 24976760)
28. Gonzalez JS, Fisher L, Polonsky WH. Depression in diabetes: have we been missing something important? Diabetes Care 2011;34:236-239
29. Aronne LJ, Segal KR. Weight gain in the treatment of mood disorders. J Clin Psychiatry 2003;64(Suppl. 8):22-29 (Pubitemid 36903904)
30. McIntyre RS, Park KY, Law CWY, et al. The association between conventional antidepressants and the metabolic syndrome: A review of the evidence and clinical implications. CNS Drugs 2010; 24:741-753
31. Licht CM, de Geus EJ, Seldenrijk A, et al. Depression is associated with decreased blood pressure, but antidepressant use increases the risk for hypertension. Hypertension 2009;53:631-638
32. Kemp AH, Quintana DS, Gray MA, Felmingham KL, Brown K, Gatt JM. Impact of depression and antidepressant treatment on heart rate variability: A review and meta-analysis. Biol Psychiatry 2010;67:1067-1074
33. Physicians Desk Reference. 22nd ed. Mon-tvale, NJ, Thompson PDR, 2008
34. Saydah SH, Fradkin J, Cowie CC. Poor control of risk factors for vascular disease among adults with previously diagnosed diabetes. JAMA 2004;291:335-342 (Pubitemid 38101606)